Abstract:Objectives Increasing evidences shown the important role of bone marrow-derived mesenchymal stem cells (BM-MSCs) in wound healing and vascular remodelling in vivo. However, their mechanism in the development of atherosclerosis and vessel calcify remain unclear. Objective To investigate the effects of Oxidatively Modified Low Density Lipoprotein (ox-LDL ) on proliferation and osteodiferenliation of BM-MSCs that Co-cultured with Smooth Muscle Cells with or without osteogenic inductor being then we try to explain the mechanism of how MSCs participate in atherosclerosis. Methods BM-MSCs and VSMCs were prepared from SD rats and co-cultured in a Transwell system, which allowed the diffusion of secreted factors but prevented cell contact between the two cell types. Four groups were designed according as factorial design, which were Combine group (both osteogenic inductor and ox-LDL), ox-LDL group, Osteogenic inductor group and control group. The proliferation of BM-MSCs was determined by MTT assay. The their effects on the osteogenic potential of BM-MSCs by cell morphology, real-time PCR, immunofluorescent staining, alkaline phosphatase (AKP) activity and Osteopontin (OPN) synthesis. Results 1. The growth curve showed that cells number of all four groups increased along with time. The ability of promoting cellular proliferation in ox-LDL (5 mg/L) group were showed strongest in four groups, but that of combine group were opposite at 7days, 10 days and 14 days. 2. At the cultured 7 days, 10 days, all groups express OPN mRNA and AKP and but the combine group was highest. There was interaction between the two factors (P < 0.01). 3. The result of Immunity histochemistry showed that the rate of OPN and AKP positive cells in combine group were the highest at 14 days. Conclusions Increasing evidences indicated a link between bone marrow cells and the pathogenesis of atherosclerosis. It was recognized that a higher percentage of circulating endothelial progenitor cells expressed osteocalcin in patients with coronary atherosclerosis. Widespread increased myeloid calcifying cells contribute to ectopic vascular calcification in type 2 diabetes. Furthermore, mouse model and human studies have suggested that bone marrow-derived progenitor cells may contribute to a variety of vascular pathologies including calcification, atherosclerosis and intimal hyperplasia. In view of the capacity of differentiation into osteoblast from BM-MSCs, we investigated whether BM-MSCs was involved in the process of angiosteosis in atherosclerosis when exposed to vascular injure and hyperlipemia. Thus, we mimicked the phenotype transformation of VSMC exposed to hyperlipemia to investigate the differentiation of BM-MSCs. Data reported in this study demonstrated that ox-LDL significantly promoted proliferation of BM-MSCs co-cultured with VSMC, but not osteoblast differentiation. The proproliferative role of ox-LDL was neutralised by Osteogenic inductor, but apoptosis was induced instead. We results showed that ox-LDL can promote the proliferation of BM-MSCs, and Osteogenic Inductor mediated Osteodifferentiation marker expression in BM-MSCs in vitro.

Indirect co‑culture of vascular smooth muscle cells with bone marrow mesenchymal stem cells inhibits vascular calcification and downregulates the Wnt signaling pathways.

Low magnitude high frequency vibration promotes chondrogenic differentiation of bone marrow stem cells with involvement of β-catenin signaling pathway.

Exosomes Derived from Mesenchymal Stromal Cells Pretreated with Advanced Glycation End Product-Bovine Serum Albumin Inhibit Calcification of Vascular Smooth Muscle Cells

The Emerging Role of Mesenchymal Stem Cells in Vascular Calcification

Mesenchymal stem cells recruited by active TGFβ contribute to osteogenic vascular calcification.

Bone marrow mesenchymal stem cell-derived exosomes alleviate high phosphorus-induced vascular smooth muscle cells calcification by modifying microRNA profiles

GW24-e2290 Effects of Oxidatively Modified Low Density Lipoprotein on Proliferation and Osteodifferentiation of Mesenchymal Stem Cells That Co-Cultured with Vascular Smooth Muscle Cells

Tension-loaded Bone Marrow Stromal Cells Potentiate the Paracrine Osteogenic Signaling of Co-Cultured Vascular Endothelial Cells

The miR-29b/Matrix Metalloproteinase 2 Axis Regulates Transdifferentiation and Calcification of Vascular Smooth Muscle Cells in a Calcified Environment

Inhibiting expression of Cxcl9 promotes angiogenesis in MSCs-HUVECs co-culture.

Mesenchymal Stromal Cells Regulate the Cell Mobility and the Immune Response During Osteogenesis Through Secretion of Vascular Endothelial Growth Factor A

Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases

Overexpression of miR-204-5p Alleviates Osteogenic Differentiation and Calcification of Human Aortic Vascular Smooth Muscle Cells by Targeting Calcium/Calmodulin-dependent Protein Kinase 1

Effect of Cell-Cell Direct Contact to Mesenchymal Stem Cells Differentiate into Vascular Endothelial Cells

The Effect of High Calcium and High Phosphate on Calcification of Rat VSMCs

Effects of BMP2 and VEGF165 on the Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells.

Indoxyl Sulfate Promotes Osteogenic Differentiation of Vascular Smooth Muscle Cells by Mir-155-5p-dependent Downregulation of Matrix Gla Protein Via ROS/NF-κB Signaling

Osteogenically Differentiated Mesenchymal Stem Cells Promote the Apoptosis of Human Umbilical Vein Endothelial Cells in Vitro

Mir-195-5p targets Smad7 regulation of the Wnt/β-catenin pathway to promote osteogenic differentiation of vascular smooth muscle cells

In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds

MicroRNA-205 Regulates the Calcification and Osteoblastic Differentiation of Vascular Smooth Muscle Cells